• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients.

作者信息

Moertl Deddo, Hammer Alexandra, Huelsmann Martin, Pacher Richard, Berger Rudolf

机构信息

Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

出版信息

Eur J Heart Fail. 2008 Apr;10(4):404-11. doi: 10.1016/j.ejheart.2008.02.018. Epub 2008 Mar 20.

DOI:10.1016/j.ejheart.2008.02.018
PMID:18358775
Abstract

BACKGROUND

We evaluated the prognostic value of sequential NT-proBNP values in ambulatory heart failure patients after discharge, investigating whether the current value or the recent percent change is more important.

METHODS AND RESULTS

In 166 patients, NT-proBNP was measured at discharge from heart failure hospitalisation and three months later. The combined endpoint of death or heart failure rehospitalisation was evaluated after a maximum of 18 months or at follow-up closure. During a mean observation time of 14+/-4 months, 63 patients (38%) reached the endpoint. In multiple Cox analysis, NT-proBNP three months after discharge (NT-proBNP-3Mo) and NT-proBNP percent change (NT-proBNP-%change) were the only independent predictors of the endpoint among various clinical and laboratory variables. After definition of a high- (n=83, 57% endpoints) and a low-NT-proBNP patient subgroup (n=83, 19% endpoints) according to the median NT-proBNP-3Mo (1751 pg/ml), NT-proBNP-%change was the strongest predictor in the high-NT-proBNP subgroup. In the low-NT-proBNP subgroup, NT-proBNP-3Mo was the only independent predictor.

CONCLUSIONS

In ambulatory heart failure patients, the prognostic value of sequential NT-proBNP measurements depends on the magnitude of the current NT-proBNP value. Recent percent changes in NT-proBNP provide important prognostic information in patients with high NT-proBNP but not in patients with low NT-proBNP.

摘要

相似文献

1
Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients.
Eur J Heart Fail. 2008 Apr;10(4):404-11. doi: 10.1016/j.ejheart.2008.02.018. Epub 2008 Mar 20.
2
Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.心力衰竭患者住院期间 N 末端 B 型利钠肽原的急性变化与再入院和死亡率的关系。
Am J Cardiol. 2011 Apr 15;107(8):1191-5. doi: 10.1016/j.amjcard.2010.12.018. Epub 2011 Feb 4.
3
Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.血浆 N 末端脑利钠肽前体无下降可识别急性心力衰竭预后极差的患者。
Int J Cardiol. 2008 Oct 13;129(3):373-8. doi: 10.1016/j.ijcard.2007.07.126. Epub 2007 Dec 4.
4
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.比较中段心房利钠肽原与N末端B型利钠肽原在预测慢性心力衰竭患者生存率中的作用
J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29.
5
A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure.N末端前脑钠肽的变化可预测晚期心力衰竭患者的预后。
Eur J Heart Fail. 2007 Mar;9(3):266-71. doi: 10.1016/j.ejheart.2006.07.002. Epub 2006 Oct 4.
6
Pro-B-type natriuretic peptide levels in acute decompensated heart failure.急性失代偿性心力衰竭患者的前B型利钠肽水平
J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.
7
Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization.住院期间NT-proBNP的变化可预测收缩功能保留的失代偿性心力衰竭患者的预后。
Int J Cardiol. 2007 Apr 12;117(1):75-9. doi: 10.1016/j.ijcard.2006.06.004. Epub 2006 Jul 14.
8
N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.急诊科N末端前脑钠肽检测:对住院治疗、费用及结局的有益影响
Am Heart J. 2008 Jul;156(1):71-7. doi: 10.1016/j.ahj.2008.02.021. Epub 2008 May 27.
9
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.N末端前脑钠肽可预测心力衰竭患者出院后的预后。
Circulation. 2004 Oct 12;110(15):2168-74. doi: 10.1161/01.CIR.0000144310.04433.BE. Epub 2004 Sep 27.
10
Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.氨基末端B型利钠肽、肾功能与急性心力衰竭的预后:一项医院队列研究
J Card Fail. 2007 May;13(4):275-80. doi: 10.1016/j.cardfail.2007.01.001.

引用本文的文献

1
Improved outcome with standardized plan for clinical management of acute decompensated chronic heart failure.采用标准化方案对急性失代偿性慢性心力衰竭进行临床管理可改善预后。
J Geriatr Cardiol. 2019 Jan;16(1):12-18. doi: 10.11909/j.issn.1671-5411.2019.01.002.
2
BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.B型利钠肽和N末端B型利钠肽原作为慢性稳定型心力衰竭患者的预后标志物
Heart Fail Rev. 2014 Aug;19(4):471-505. doi: 10.1007/s10741-014-9439-6.
3
Effect of enhanced external counterpulsation treatment on renal function in cardiac patients.
增强型体外反搏治疗对心脏病患者肾功能的影响。
BMC Nephrol. 2013 Sep 11;14:193. doi: 10.1186/1471-2369-14-193.
4
Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.N-末端脑利钠肽前体在心力衰竭和其他心血管疾病中的临床应用。
Heart Fail Rev. 2010 Jul;15(4):293-304. doi: 10.1007/s10741-009-9142-1.